EMP2 and breast carcinoma: A panel of six genes: CCNE2, DKFZp762E1312, EMP2, MAL2, PPIC, and SLC6A8 that were over-expressed in the blood of 81% of patients with recurrent breast cancer was then chosen as gene markers for the molecular detection of CTC.